HopeStage
Back to all studies
RecruitingNCT06289621

Brief transdiagnostic therapy for anxiety and PTSD in South African primary care

About this title

Brief Transdiagnostic Treatment for Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) in South Africa

Read the official source — NCT06289621
Behavioural studyAges 18–65South Africa
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Cape TownSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 8, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural
Locations
South Africa
Age range
From 18 Years to 65 Years
Official registry ID
NCT06289621
Official title
Show the full official title

Brief Transdiagnostic Treatment for Anxiety Disorders and PTSD in South Africa: A Hybrid-Effectiveness-Implementation Trial

Recruitment & locations

Currently recruiting

Cape Town

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies